Pfizer/BioNTech
Moderna Inc on Wednesday said that it had started a mid-stage study, testing a booster dose specifically designed to target the Omicron variant of the virus, a day after rival Pfizer Inc launched a similar trial.
Pfizer Inc Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.
The government have decided to administer the Moderna COVID-19 vaccine as booster shots instead of the Pfizer vaccine.
Pfizer expects a vaccine targeting the Omicron variant to be ready in March, said Pfizer Chief Executive Officer Albert Bourla on Monday.
A US Centers for Disease Control and Prevention report on Friday said that two doses of the Pfizer Inc and BioNTech COVID-19 vaccine are highly protective against a rare but often serious condition in children that causes organ inflammation weeks after COVID-19 infections.
The US Centers for Disease Control and Prevention (CDC) said on Wednesday it expanded the eligibility of Pfizer Inc and BioNTech SE’s booster doses to those 12 to 15 years old.
Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron strain, the companies warned Wednesday, but they stressed it was ‘still effective’ after a third jab.
The United States has donated another 1.8 million doses of Pfizer’s COVID-19 vaccine to Bangladesh.
Pfizer Inc has applied for approval from Japan’s health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.
Oral antiviral pills from Merck & Co and Pfizer Inc-BioNTech SE have been shown to significantly blunt the worst outcomes of COVID-19 if taken early enough, but doctors warn vaccine hesitant people not to confuse the benefit of the treatments with prevention afforded by vaccines.
The United States on Friday authorized the Pfizer Covid vaccine for children aged 5 to 11, paving the way for 28 million young Americans to soon get immunized.
A booster shot of the anti-COVID-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on Thursday.
School students, between 12-17 years of age, will be vaccinated with Pfizer COVID-19 jabs at the Colonel Malek Medical College Hospital in Manikganj on Thursday.
The effectiveness of the Pfizer/BioNTech vaccine in preventing infection by the coronavirus dropped to 47 percent from 88 percent six months after the second dose, according to data published on Monday that US health agencies considered when deciding on the need for booster shots.
Bangladesh will get 7.1 million doses of Pfizer and 1.8 million of Moderna vaccines as part of US donation and regular supply under the Covax facility.
A new study by the US Centers for Disease Control and Prevention (CDC) on Friday revealed that the Moderna COVID-19 vaccine confers better long-term protection against hospitalization than Pfizer.
Students aged between 12 and 17 years will receive the Pfizer vaccine.
Japanese Prime Minister Yoshihide Suga on Tuesday received the first dose of Pfizer vaccine at a hospital in Tokyo.
The World Health Organization (WHO) on Friday granted the Johnson & Johnson’s COVID-19 vaccine for emergency use.
